Please provide your email address to receive an email when new articles are posted on . LV hypertrophy without high BP increased risk for CV events, CV death and HF hospitalization. The dual ...

Please provide your email address to receive an email when new articles are posted on . Malignant left ventricular hypertrophy, a subtype in which patients have elevations in cardiac biomarkers ...

Mavacamten was found to improve left ventricular hypertrophy in patients with obstructive hypertrophic cardiomyopathy. Mavacamten was found to improve left ventricular (LV) hypertrophy in patients ...

Elevated left ventricular mass, known as left-ventricular hypertrophy, is a stronger predictor of coronary artery disease-related death and heart failure than coronary artery calcium score, according ...

Investigators conducted this subanalysis among patients aged 20 to 27 years, using data from the National Growth and Health Study to determine potential racial differences in left ventricular mass ...

Several lines of evidence based on cross-sectional and longitudinal studies point to a reduced nocturnal BP fall as a marker of subclinical (i.e., LVH, renal and vascular damage) and overt CV ...

A new deep-learning algorithm can better identify subtle left ventricular (LV) wall geometric measurements on echocardiography than expert physicians, as validated on three international cohorts, a ...

Patients with severe symptomatic aortic stenosis at intermediate and high risk for surgery who, after TAVR, have a larger regression in left ventricular mass at 1 year will then go on to have ...

Hearts of young cyclists show greater exercise-related adaptation, including more left ventricular enlargement and changes on ...

Prolonged treatment with hydroxyurea may improve -- and possibly even reverse -- cardiac complications in pediatric patients with sickle cell anemia, a retrospective study found. Those on hydroxyurea ...